BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1749934)

  • 1. Heterogeneous amino acids in Ras and Rap1A specifying sensitivity to GAP proteins.
    Zhang K; Papageorge AG; Martin P; Vass WC; Olah Z; Polakis PG; McCormick F; Lowy DR
    Science; 1991 Dec; 254(5038):1630-4. PubMed ID: 1749934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid 61 is a determinant of sensitivity of rap proteins to the ras GTPase activating protein.
    Hart PA; Marshall CJ
    Oncogene; 1990 Jul; 5(7):1099-101. PubMed ID: 2115644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rap1A antagonizes the ability of Ras and Ras-Gap to inhibit muscarinic K+ channels.
    Yatani A; Quilliam LA; Brown AM; Bokoch GM
    J Biol Chem; 1991 Nov; 266(33):22222-6. PubMed ID: 1939245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product.
    Frech M; John J; Pizon V; Chardin P; Tavitian A; Clark R; McCormick F; Wittinghofer A
    Science; 1990 Jul; 249(4965):169-71. PubMed ID: 2164710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COOH-terminal domain of the Rap1A (Krev-1) protein is isoprenylated and supports transformation by an H-Ras:Rap1A chimeric protein.
    Buss JE; Quilliam LA; Kato K; Casey PJ; Solski PA; Wong G; Clark R; McCormick F; Bokoch GM; Der CJ
    Mol Cell Biol; 1991 Mar; 11(3):1523-30. PubMed ID: 1899909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization of baculovirus-expressed rap1A/Krev-1 and its regulation by GTPase-activating proteins.
    Quilliam LA; Der CJ; Clark R; O'Rourke EC; Zhang K; McCormick F; Bokoch GM
    Mol Cell Biol; 1990 Jun; 10(6):2901-8. PubMed ID: 2160589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain.
    Adari H; Lowy DR; Willumsen BM; Der CJ; McCormick F
    Science; 1988 Apr; 240(4851):518-21. PubMed ID: 2833817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.
    Nur-E-Kamal MS; Varga M; Maruta H
    J Biol Chem; 1993 Oct; 268(30):22331-7. PubMed ID: 8226742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic amino acid substitutions in the inhibitory rap-1A protein cause it to adopt a ras-p21-like conformation as computed using molecular dynamics.
    Chen JM; Brandt-Rauf PW; Pincus MR
    J Biomol Struct Dyn; 1996 Jun; 13(6):925-33. PubMed ID: 8832375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
    Marshall MS; Hettich LA
    Oncogene; 1993 Feb; 8(2):425-31. PubMed ID: 8426748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The residues of Ras and Rap proteins that determine their GAP specificities.
    Maruta H; Holden J; Sizeland A; D'Abaco G
    J Biol Chem; 1991 Jun; 266(18):11661-8. PubMed ID: 1828804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.
    Andersen LB; Ballester R; Marchuk DA; Chang E; Gutmann DH; Saulino AM; Camonis J; Wigler M; Collins FS
    Mol Cell Biol; 1993 Jan; 13(1):487-95. PubMed ID: 8417346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma membrane-targeted ras GTPase-activating protein is a potent suppressor of p21ras function.
    Huang DC; Marshall CJ; Hancock JF
    Mol Cell Biol; 1993 Apr; 13(4):2420-31. PubMed ID: 8455619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Gln61 and Glu63 of Ras GTPases in their activation by NF1 and Ras GAP.
    Nur-E-Kamal MS; Maruta H
    Mol Biol Cell; 1992 Dec; 3(12):1437-42. PubMed ID: 1362901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of cellular activities by GTPase-activating protein and NF1.
    al-Alawi N; Xu G; White R; Clark R; McCormick F; Feramisco JR
    Mol Cell Biol; 1993 Apr; 13(4):2497-503. PubMed ID: 8455625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
    Stang S; Bottorff D; Stone JC
    Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S; Maekawa M; Nakamura S
    Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial purification of a GTPase-activating protein for rap2b from bovine brain membranes.
    Farrell FX; Lapetina EG
    Biochem Biophys Res Commun; 1992 Dec; 189(2):717-21. PubMed ID: 1472043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of rasGAP and neurofibromatosis gene product activities.
    Bollag G; McCormick F
    Nature; 1991 Jun; 351(6327):576-9. PubMed ID: 1904555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.
    Martin GA; Viskochil D; Bollag G; McCabe PC; Crosier WJ; Haubruck H; Conroy L; Clark R; O'Connell P; Cawthon RM
    Cell; 1990 Nov; 63(4):843-9. PubMed ID: 2121370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.